Marc Van Damme

Characterization of the activities of actin-affecting drugs on tumor cell migration

Caroline Hayot, Olivier Debeir, Philippe Van Ham et al. · Toxicology and Applied Pharmacology · 2005 · 146 citations

Life Sciences, Cell Biology, Oncology +14

4-IBP, a σ1 Receptor Agonist, Decreases the Migration of Human Cancer Cells, Including Glioblastoma Cells, In Vitro and Sensitizes Them In Vitro and In Vivo to Cytotoxic Insults of Proapoptotic and Proautophagic Drugs

Véronique Mégalizzi, Véronique Mathieu, Tatjana Mijatovic et al. · Neoplasia · 2007 · 95 citations · Full text

Medicine, Oncology, Pharmacology +16

In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton

Caroline Hayot, Sophie Farinelle, Robert De Decker et al. · International Journal of Oncology · 2002 · 91 citations

Medicine, Oncology, Pharmacology +14

Investigations of Fungal Secondary Metabolites with Potential Anticancer Activity

E.S. Baldé, Anna Andolfi, Céline Bruyère et al. · Journal of Natural Products · 2010 · 58 citations

Life Sciences, Oncology, Pharmacology +13

Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model

Mark R. Schleiss, K. Yeon Choi, Jodi Anderson et al. · Vaccine · 2013 · 51 citations

Veterinary Medicine, Immunology, Infectious Diseases +15